Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
NCT: NCT04829357 · RECRUITING
Brief Summary
The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).
Frequently Asked Questions
What is Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System?
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System is a clinical trial registered under NCT04829357. Current status: RECRUITING.
What is the status of NCT04829357?
The current status of NCT04829357 (Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System) is: RECRUITING.
When did Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System start?
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System started on 2021-09-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.